Tejada Juan G, Lopez Gloria Vv, Koovor Jerry Me, Riley Kalen, Martinez Mesha
Eskenazi Health, Indianapolis, USA.
University of Iowa, Iowa City, USA.
Interv Neuroradiol. 2019 Dec;25(6):664-670. doi: 10.1177/1591019919853586. Epub 2019 Jun 3.
Endovascular treatment of large complex morphology aneurysms is challenging. High recanalization rates have been reported with techniques such as stent-assisted coiling and balloon-assisted coiling. Flow diverter devices have been introduced to improve efficacy outcomes and recanalization rates. Thromboembolic complications and in-device stenosis are certainly more worrisome when treatment of bilateral internal carotid arteries has been performed. This study aimed to report our experience with mid-term imaging follow-up of staged bilateral Pipeline embolization device placement for the treatment of bilateral internal carotid artery aneurysms.
We reviewed the clinical, angiographic, and follow-up imaging data in all consecutive patients treated with bilateral internal carotid artery aneurysms who underwent elective Pipeline embolization.
Six female patients were treated, harboring a total of 13 aneurysms. Of these, 60% were asymptomatic. Diplopia and headache were the most common symptoms. The most common location was the paraclinoid segment (6/13), including by cavernous segment (4/13) and ophthalmic segment (2/13). Successful delivery of the device was achieved in 12 cases. Difficult distal access precluded the deployment of the device in one case. The treatment was always staged with at least eight weeks' difference between the two procedures. All aneurysm necks were covered completely. There were no periprocedural complications. Angiographic follow-up ranged between 3 and 12 months, and computed tomography angiogram follow-up ranged between 2 and 24 months. Complete aneurysm occlusion was achieved in all cases.
In our series, Pipeline deployment for the treatment of bilateral internal carotid artery aneurysms in a staged fashion is safe and feasible. Mid-term imaging follow-up showed permanent occlusion of all the treated aneurysms.
大型复杂形态动脉瘤的血管内治疗具有挑战性。据报道,支架辅助弹簧圈栓塞和球囊辅助弹簧圈栓塞等技术的再通率较高。血流导向装置已被引入以改善疗效和再通率。当双侧颈内动脉均接受治疗时,血栓栓塞并发症和装置内狭窄无疑更令人担忧。本研究旨在报告我们对分期双侧植入Pipeline栓塞装置治疗双侧颈内动脉动脉瘤的中期影像随访经验。
我们回顾了所有接受选择性Pipeline栓塞治疗双侧颈内动脉动脉瘤的连续患者的临床、血管造影和随访影像数据。
6例女性患者接受了治疗,共患有13个动脉瘤。其中,60%无症状。复视和头痛是最常见的症状。最常见的部位是床突旁段(6/13),包括海绵窦段(4/13)和眼段(2/13)。12例成功植入装置。1例因远端通路困难未能植入装置。治疗总是分期进行,两次手术之间至少间隔8周。所有动脉瘤颈均被完全覆盖。术中无并发症。血管造影随访时间为3至12个月,计算机断层血管造影随访时间为2至24个月。所有病例均实现了动脉瘤完全闭塞。
在我们的系列研究中,分期植入Pipeline治疗双侧颈内动脉动脉瘤是安全可行的。中期影像随访显示所有治疗的动脉瘤均永久性闭塞。